Estrogen has anti-amyloidogenic effects on Alzheimer's β-amyloid fibrils in vitro

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 697-702

  Morinaga, Akiyoshi ^a   Hirohata, Mie ^a   Ono, Kenjiro ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyloid fibrils; Alzheimer's disease; Anti amyloidogenic effects; Electron microscopy; Estrogen; Sexual steroids; Thioflavin T

Indexed keywords

AMYLOID BETA PROTEIN; ANDROSTENEDIONE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; TESTOSTERONE; THIOFLAVINE;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; DOSE RESPONSE; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; PH; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; TEMPERATURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ESTROGENS; MICROSCOPY, ELECTRON; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS;

EID: 34250220693     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.158     Document Type: Article

References (26)

1. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
2. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., and Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 (1995) 253-265
3. Jorm A.F., Korten A.E., and Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta. Psychiatr. Scand. 76 (1987) 465-479
4. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R., Dartigues J.F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., and Hofman A. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53 (1999) 1992-1997
5. Henderson V.W., Paganini-Hill A., Emanual C.K., Dunn M.E., and Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51 (1994) 896-900
6. Yaffe K., Sawaya G., Lieberburg I., and Grady D. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 279 (1998) 688-695
7. Hogervorst E., Williams J., Budge M., Riedel W., and Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101 (2000) 485-512
8. LeBlanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systemic review and meta-analysis. JAMA 285 (2001) 1489-1499
9. Li R., Shen Y., Yang L.B., Leu L.F., Finch C., and Rogers J. Estrogen enhances uptake of amyloid β-protein by microglia derived from the human cortex. J. Neurochem. 75 (2000) 1447-1454
10. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., Harada N., Zhong Z., Shen Y., and Li R. Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. USA 102 (2005) 19198-19203
11. Petanceska S.S., Nagy V., Frail D., and Gandy S. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Neurology 54 (2000) 2212-2217
12. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogen attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
13. Pinkerton J.V., and Henderson V.W. Estrogen and cognition, with a focus on Alzheimer's disease. Semin. Reprod. Med. 23 (2005) 172-179
14. Ono K., Noguchi M., Matsumoto Y., Yanase D., Iwasa K., Naiki H., and Yamada M. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro. Neurobiol. Dis. 20 (2005) 233-240
15. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
16. Ono K., Hasegawa K., Yoshiike Y., Takashima A., Yamada M., and Naiki H. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's β-amyloid fibrils in vitro. J. Neurochem. 81 (2002) 434-440
17. Ono K., Hamaguchi T., Naiki H., and Yamada M. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease. Biochim. Biophys. Acta 1762 (2006) 575-586
18. Hirohata M., Hasegawa K., Tsutsumi-Yasuhara S., Ohhashi Y., Ookoshi T., Ono K., Yamada M., and Naiki H. The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46 (2007) 1888-1899
19. Naiki H., and Nakakuki K. First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro. Lab. Invest. 74 (1996) 374-383
20. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., and Endo N. Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271 (1996) 6839-6844
21. Behl C., Skutella T., Lezoualch F., Post A., Widmann M., Newton C.J., and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 (1997) 535-541
22. Longcope C. Methods and results of aromatization studies in vivo. Cancer Res. 42 (1982) 3307s-3311s
23. Manly J.J., Merchant C.A., Jacobs D.M., Small S.A., Bell K., Ferin M., and Mayeux R. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54 (2000) 833-837
24. Schonknecht P., Pantel J., Klinga K., Jensen M., Hartmann T., Salbach B., and Schroder J. Reduced cerebrospinal fluid estradiol levels are associated with increased β-amyloid levels in female patients with Alzheimer's disease. Neurosci. Lett. 307 (2001) 122-124
25. Molnar G., and Kassai-Bazsa Z. Gonadotoropin, ACTH, prolactin, sexual steroid and cortisol levels in postmenopausal women's cerebrospinal fluid (CSF). Arch. Gerontol. Geriatr. 24 (1997) 269-280
26. Lobo R.A., Brenner P., and Mishell D.R. Metabolic parameters and steroid levels in postmenopausal women receiving lower doses of natural estrogen replacement. Obstet. Gynecol. 62 (1983) 94-98